Compound Detail
CHEMBL714
ALBUTEROL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL714 |
| Name | ALBUTEROL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NDAUXUAQIAJITI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
6
Targets
27
Activities
4
Assay Types
18
PK Parameters
20
Publications
30
Known Names
20
Indications
1
Mechanisms
Molecular Properties
239.3
MW (Da)
1.31
ALogP
4
HBA
4
HBD
72.7
PSA (Ų)
0.64
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1981 |
| Availability | Prescription |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-2 adrenergic receptor agonist | AGONIST | Beta-2 adrenergic receptor | ✓ | ✓ |
Indications
Asthma, Exercise-Induced Bronchial Spasm Bronchial Spasm Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Abdominal Pain Dysautonomia, Familial Heart Failure Heart Failure Hypertension, Pulmonary Hypertension, Pulmonary Lung Diseases Organophosphate Poisoning Rhinitis, Allergic, Seasonal Bronchiolitis Cough Familial Primary Pulmonary Hypertension Hypersensitivity Memory Disorders Pulmonary Edema
ATC Classification
R03AC02
salbutamol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03CC02
salbutamol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Drug Warnings
Black Box Warning
General Warning
Activity Summary
EC50 11 meas. best 9.96
Kd 6 meas. best 6.96
IC50 5 meas. best 7.77
Ki 5 meas. best 6.29
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 9.96 | 7.606 | 0.1 | 5 |
| Beta-2 adrenergic receptor CHEMBL5414 | EC50 | 9.34 | 7.9833 | 0.5 | 3 |
| Beta-1 adrenergic receptor CHEMBL213 | EC50 | 8.81 | 7.37 | 1.5 | 2 |
| Beta-2 adrenergic receptor CHEMBL5414 | IC50 | 7.77 | 7.77 | 17.0 | 1 |
| Cavia porcellus CHEMBL369 | IC50 | 7.75 | 7.75 | 18.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 7.12 | 7.12 | 75.9 | 1 |
| Beta-2 adrenergic receptor CHEMBL5414 | Kd | 6.96 | 6.5033 | 109.7 | 3 |
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 6.66 | 6.255 | 220.0 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 6.29 | 6.0933 | 510.0 | 3 |
| Beta-2 adrenergic receptor CHEMBL3373 | Kd | 6.28 | 6.28 | 520.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 6.09 | 5.9333 | 810.2 | 3 |
| Unchecked CHEMBL612545 | Ki | 5.88 | 5.775 | 1320.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 7.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 7.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 7.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 79.9 | mL.min-1.kg-1 | Mus musculus |
| CL | 1.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 7.7 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 58.0 | nM | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| Fu | 0.92 | - | Homo sapiens |
| Fu | 0.92 | - | Homo sapiens |
| Fu | 0.925 | - | Homo sapiens |
| MRT | 4.1 | hr | Homo sapiens |
| T1/2 | 2.4 | hr | Homo sapiens |
| T1/2 | 0.6 | hr | Mus musculus |
| T1/2 | 3.9 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine